Zymeworks ZYME
NASDAQ ZYME
$26.49 -0.71 (-2.61%)
At close: Sep 30, 2026 · 4:00 PM EDT

Zymeworks (ZYME) Liabilities and Shareholders Equity (2021 - 2026)

Updated

Zymeworks (ZYME) reported Liabilities and Shareholders Equity of $396.96 million for Q2 2026, down 2.8% from $408.39 million a year earlier and down 17.0% from the prior quarter.

Analysis

Zymeworks (ZYME) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

At the end of FY2025, Zymeworks posted Liabilities and Shareholders Equity of $346.53 million, down 25.2% from FY2024.

  • Liabilities and Shareholders Equity has declined for three consecutive years, with a four-year compound annual growth rate of -2.9% (FY2021 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $463.09 million in FY2024 (-20.3%), $580.88 million in FY2023 (-10.5%), $648.73 million in FY2022 (+66.7%) and $389.13 million in FY2021.
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $300.26 million in Q3 2022 and a high of $648.73 million in Q4 2022.
  • Year over year, Liabilities and Shareholders Equity gained in 1 of the last eight quarters, with an average decline of 13.8%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q3 2023 (growth of 85.3%); the low point was Q4 2025 (a decline of 25.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $478.22 million (Q1 2026), $346.53 million (Q4 2025) and $397.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Zymeworks 1.89 Bn 775.55 Mn - 396.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 396.96 Mn
Mar 31, 2026 478.22 Mn
Dec 31, 2025 346.53 Mn
Sep 30, 2025 397.27 Mn
Jun 30, 2025 408.39 Mn
Mar 31, 2025 425.52 Mn
Dec 31, 2024 463.09 Mn
Sep 30, 2024 487.15 Mn
Jun 30, 2024 515.63 Mn
Mar 31, 2024 553.75 Mn
Dec 31, 2023 580.88 Mn
Sep 30, 2023 556.37 Mn
Jun 30, 2023 602.05 Mn
Mar 31, 2023 600.74 Mn
Dec 31, 2022 648.73 Mn
Sep 30, 2022 300.26 Mn
Dec 31, 2021 389.13 Mn
API Access

Zymeworks Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ZYME&period=max&api_key=YOUR_API_KEY